Nose-to-Brain Drug Delivery and Physico-Chemical Properties of Nanosystems: Analysis and Correlation Studies of Data from Scientific Literature
DOI: https://doi.org/10.2147/ijn.s452316
IF: 7.033
2024-06-12
International Journal of Nanomedicine
Abstract:Angela Bonaccorso, 1, 2, &ast Alessandro Ortis, 3, &ast Teresa Musumeci, 1, 2 Claudia Carbone, 1, 2 Mazhar Hussain, 3 Valentina Di Salvatore, 1 Sebastiano Battiato, 3 Francesco Pappalardo, 1, 2 Rosario Pignatello 1, 2 1 Department of Drug and Health Sciences, University of Catania, Catania, Italy; 2 NANOMED–Research Centre for Nanomedicine and Pharmaceutical Nanotechnology, University of Catania, Catania, 95125, Italy; 3 Department of Mathematics and Computer Science, University of Catania, Catania, Italy &astThese authors contributed equally to this work Correspondence: Teresa Musumeci, Email Background: In the last few decades, nose-to-brain delivery has been investigated as an alternative route to deliver molecules to the Central Nervous System (CNS), bypassing the Blood–Brain Barrier. The use of nanotechnological carriers to promote drug transfer via this route has been widely explored. The exact mechanisms of transport remain unclear because different pathways (systemic or axonal) may be involved. Despite the large number of studies in this field, various aspects still need to be addressed. For example, what physicochemical properties should a suitable carrier possess in order to achieve this goal? To determine the correlation between carrier features (eg, particle size and surface charge) and drug targeting efficiency percentage (DTE%) and direct transport percentage (DTP%), correlation studies were performed using machine learning. Methods: Detailed analysis of the literature from 2010 to 2021 was performed on Pubmed in order to build "NANOSE" database. Regression analyses have been applied to exploit machine-learning technology. Results: A total of 64 research articles were considered for building the NANOSE database (102 formulations). Particle-based formulations were characterized by an average size between 150– 200 nm and presented a negative zeta potential (ZP) from − 10 to − 25 mV. The most general-purpose model for the regression of DTP/DTE values is represented by Decision Tree regression, followed by K-Nearest Neighbors Regressor (KNeighbor regression). Conclusion: A literature review revealed that nose-to-brain delivery has been widely investigated in neurodegenerative diseases. Correlation studies between the physicochemical properties of nanosystems (mean size and ZP) and DTE/DTP parameters suggest that ZP may be more significant than particle size for DTP/DTE predictability. Keywords: nanomedicine, intranasal administration, pharmacokinetic, DTE, DTP, machine learning The treatment of Central Nervous System (CNS) diseases remains an urgent challenge because of the presence of the blood-brain-barrier (BBB), which rigorously controls the entry of substances into the brain and, with the same mechanism, limits the passage of most therapeutic molecules. 1 To overcome the limitations of the BBB and adequately treat CNS diseases, in recent decades, different strategies have been explored by the scientific community, such as the use of nanomedicines, viral vectors, drug delivery by active transporters or receptors, and brain permeability enhancers. 2 Currently, a widely explored strategy to reach the brain is the intranasal (IN) route, which represents a promising approach for bypassing the BBB. 3 Although the mechanism(s) by which the drug reaches the brain via this route remains unclear, a combination of different pathways appears to be involved. Following IN administration, the drug reaches the vestibular region, characterized by the presence of mucus and hairs/cilia, which limit drug permanence in the nasal cavity by mucociliary clearance. 4 As a function of the device used for drug administration, the drug can be located predominantly in the respiratory or olfactory regions. The respiratory region is highly vascularized and innervated by the trigeminal nerve; thus, in this region, the drug can be absorbed into the systemic circulation and undertake an indirect route (the minor pathway) or follow the trigeminal nerve, also known as direct neuronal transport (the major pathway). 5 After systemic absorption, the drug reaches the brain and crosses the BBB. This occurs only if the drug possesses specific physicochemical properties (ie, such as lipophilicity, degree of ionization, small size, molecular weight, and low hydrogen-bonding potential). 6 The olfactory region is located in the upper part of the nasal cavity and is characterized by the presence of olfactory receptors that penetrate the CNS through their axons. Thus, a drug that reaches -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology